KLK3 and prostate carcinoma: They are in line with a study by Sasaki et al. [26] that reported a PSA nadir < 0.2 ng/mL and a prolonged time to PSA nadir following primary ADT to be early predictors of longer survival in patients with prostate cancer and bone metastasis [26].